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Abstract
Gamma interferon Inducible Lysosomal Thiol reductase (GILT) is a unique lysosomal reductase that reduces disulfide bonds
of endocytosed proteins. Lack of GILT clearly decreases CD4 T cell-antigen specific responses against some epitopes of
antigens containing disulfide bonds, but not to proteins with few or no disulfide bridges. Hence, global impact of GILT on
antigen presentation is currently not well understood. We used Nano-LC-ESI-MS/MS to investigate how GILT affects diversity
of self-peptides presented by MHC class II molecules. Surprisingly, the repertoire of self-peptides in the absence of GILT
does not appear to be significantly different, as only few peptide species (,2%) were found to be the unique indicators of
GILT’s presence or absence. In the absence of GILT about thirty peptide species (,5%) were found either uniquely or
fourteen to hundred fold more abundantly expressed than in the presence of GILT. Our data indicate that GILT has limited
yet unexpected effect on self-peptide species presented by MHC class II antigens.
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Introduction
Self-peptide/MHC complexes have several important roles in
the physiology of T cells. Engagement of the T-cell receptors with
self-peptide/MHC complex is the basis for TCR repertoire
formation in the thymus and thymocyte maturation [1].
Homeostasis of naı ¨ve T cells and maintenance of functional
competence of memory T cells in the periphery depends on the
constant engagement with self-peptide/MHC complexes [2]. In
addition, it is thought that self-peptide/MHC complexes may
modulate the strength of the immune responses to foreign antigens
[3]. Thus, alteration in processing of self-proteins may yield
peptides with different immunogenicity, thereby it may be
responsible for (or take part in) autoinflammation and responses
to cancer. Therefore it is important to identify and understand
factors that influence diversity of presented self-peptides.
Self-peptides presented by MHC class II molecules are
generated in specialized endocytic compartment with acidic
pH. Proteins imported to endosomes are first denatured by action
of GILT and further processed into peptides by cathepsins.
Peptides generated by enzymatic processing are loaded onto
MHC class II and exported to the cell surface. We have
previously shown that GILT plays an important role in
processing and presentation of exogenous proteins [4]. Our
studies indicated that GILT is involved in denaturation of
proteins containing at least four disulfide bridges, such as: Hen
Egg Lysozyme (HEL), RNAse A, insulin. Further studies
indicated that proteins that contain no disulfide bridges, for
example bovine alpha casein, do not require GILT for
processing. However, epitopes within the same protein containing
multiple disulfide bridges, such as HEL, are differentially affected
by the absence of GILT. Because of this, the effect of GILT on
global antigen processing is not readily predictable.
Here, we studied the effect of GILT on the expression of self-
peptides in the context of MHC class II. We hypothesized that
due to lack of GILT, processing of self-proteins will be altered in
such a manner that the number and/or the quantities of self-
epitopes would be diminished/reduced relative to GILT wild
type (WT) cells. To our surprise, mass spec analysis revealed
more abundant presentation of most self-peptides in the absence
of GILT, and even appearance of 10 novel epitopes. This finding
suggests that processing of a number of proteins is enhanced in
GILT2/2 splenocytes, which is in apparent contradiction to
previous observation [4] that GILT2/2 splenocytes process
certain epitopes from exogenous antigens less efficiently than the
WT cells.
Among proteins identified as the source of MHC class II
associated peptides either exclusively, or fifty or more fold
expressed in GILT2/2 cells more than in GILT-WT, are
proteins involved in apoptosis, mitosis regulation and transcription
factors. We have also validated a binding of a limited number of
peptides found to bind exclusively to GILT2/2 derived MHC
class II. Therefore, our data indicate that self-proteins involved in
some of the fundamental cellular processes might be processed
differently in the absence of GILT and presented on the cell
surface more frequently.
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Isolation of MHCclass II/peptide complexes from GILT2/2
and GILT-WT mouse splenocytes
To isolate MHC class II-bound peptide complexes, MHC class
II I-A
b molecules were purified from spleen cells derived from
GILT-WT and GILT2/2 C57BL/6 mice. NP40 cell lysates were
subjected to affinity chromatography using I-A
b-specific monoclo-
nal antibody Y3jP. The MHC class II-associated peptide fractions
were eluted with the DEA buffer and purified by RP-HPLC,
which doubled as acid elution of peptides from IA
b molecules
(Fig. 1a).
D o tb l o ta n a l y s i s( F i g .1 b )w a sp e r f o r m e dt ot e s te a c hf r a c t i o nf o r
the presence of I-A
b.A l lt h eI - A
b-positive fractions were combined
to determine the ratio of the total I-A
b protein amounts between the
GILT2/2 and the GILT-WT samples. Quantitative immunoblot
analysis by Odyssey showed that the GILT2/2/GILT-WT I-A
b
ratio was 1/1.5 (Fig. 1c). Flow cytometry analysis of splenocytes with
anti-IA
b antibody M5/114 show that GILT2/2 splenocytes
express mildly lower level of IA
b (Fig 1d).
The I-A
b-negative fractions containing short peptides (mostly
MHCII-associated peptides released from MHCII) from each
sample were pooled and prepared for iTRAQ labeling. Two
different iTRAQ reagents were used to label GILT2/2 and
GILT-WT samples separately. Once labeled, the two samples
were combined for the rest of the procedures to ensure equal
treatments to the samples.
More abundant self-peptide presentation in the absence
of GILT
The labeled samples were further separated with ion-exchange
and nano reverse phase (RP) HPLC chromatography and nano
RP-HPLC was directly interfaced with Q-TOF mass spectrometer
through Electrospray Ionization (ESI). A large amount of data
collected from the mass spectrometer was rapidly processed by
analysis software Protein PILOT with the search engine
PARAGON [5] to identify peptides sequences of I-A
b-bound
peptides which resulted in the detection of more than 5,000
peptide species. Of these, 511 distinct peptides with iTRAQ117
(GILT2/2 sample) and/or iTRAQ114 (WT sample) were
considered statistically significant based on the confidence score
associated with the peptide identification. These peptides are listed
in Table S1. Relative abundance of each peptide was determined
by the ratio of iTRAQ117 and iTRAQ114 signal intensities,
corrected by the factor of 1.5, reflecting the ratio of MHC class II
molecules in the two samples based on the quantitative
immunoblot analysis, Fig 1c. 5.5% among these peptides (28 out
of 511) were more abundant in GILT-WT samples, while the
remaining 94.5% were more abundant in GILT2/2 sample.
Only 2.0% of these (10 out of 511) were detected exclusively in
GILT2/2 samples (Table 1), and 3.5% of these peptide species
(18 out of 511) were approximately 10 to 60 fold more abundant in
GILT2/2 samples (Table S2). This is in contrast to WT sample,
where no unique peptides were detected and the peptide was only
six fold more abundant at most. The peptides found exclusively in
GILT2/2 fractions (Table 1) originate from proteins involved in
cell division, apoptosis and development, while one has unknown
function (2610002D18Rik protein).
The lengths of the MHCII-associated peptides from the
GILT2/2 sample ranged from 8 to 24 amino acids, thus not
showing any preferential binding for the peptides of certain length.
Only one of the ten peptides found exclusively in the GILT2/2
sample contained a single cysteine (SPRIQLSSCRSLESLR), while
proteins that this group of peptides originated from, all contain
multiple cysteines from just four to up to 28. All peptides except two
were positioned either at the very N or C-termini of the respective
proteins. Physical location of the peptide within the native protein
leads to differential antigen processing and consequent epitope
selection [6]. It is possible that in the folding pathway of the protein,
these regions are probably among the last to become structured,
and they would consequently be easily unfolded and preferentially
accessible to fragmentation by the proteases in the antigen-
processing pathway in the absence of GILT. Unfortunately, crystal
structures are not yet available for any of these proteins of mouse
origin therefore we can only speculate that these epitopes are
perhaps positioned in such a manner in a respective protein that
either protein denaturation facilitated by GILT is not necessary or
alternative processing takes place that is independent of GILT.
Similarly, among the peptides present in excess (at ten to sixty fold)
in MHC class II isolated from GILT2/2 samples, only two out of
18 peptides contained cysteine residues. However, all 18 peptides
originate from the proteins that contain at least one or more
cysteine in their primary sequence. Therefore, overall almost 90%
of epitopes presented exclusively or abundantly by MHC class II
from GILT2/2 samples are cysteine-free although all originate
from proteins that contain cysteines.
Together these data indicate that there is an altered and
preferential expression of self-peptides on the surface of GILT-
deficient cells. Therefore, our data support the hypothesis that the
absence of GILT alters the presentation of MHC class II
associated self-antigens, especially for the protein containing a
large number of cysteine residues. However, it is somewhat
surprising that the absence of GILT dramatically increases both
quantity and to a limited degree the diversity of presented peptides.
Detection of Peptide modifications
ProteinPILOT search engine was able to detect various peptide
modifications: oxidation (Met), deamidation (Asn and Gln),
phosphorylation (Ser, Thr, Tyr), acetylation (N-terminus),
methylthionilation and N-terminal pyroglutamate and sulfation.
Many peptides have multiple posttranslational modifications.
About 60% of the peptides (285 out of 511 peptides) were found
to have modifications, which is in a good agreement with the
current estimation that more than 50% of proteins are modified in
the physiological environment. Among the most frequent
modifications found were oxidation and deamidation. The amino
acids most susceptible to oxidation include methionine, cysteine,
histidine, and tryptophan, and the products formed from oxidation
of these residues have predictable shifts in molecular weights
compared to the molecular weights of unoxidized structures.
Because oxidation and deamidation can occur during sample
preparation or during HPLC or mass spectrometric analysis, it can
complicate interpretation [7], [8], thus these modifications are not
included in Table 2. However, other identified posttranslational
modifications require the activity of enzymes and are less likely to
be an artifact of sample handling. Samples were treated with the
mix of protease inhibitors and were kept at 4uC at all times.
Analysis of data from Table 2 reveals that there is no significant
difference in percentage of modified peptides among the peptides
that are predominantly expressed in either GILT-WT (28.6%) or
GILT2/2 (19.2%) samples. Low percentages of peptides
predominantly expressed by MHCII from GILT2/2 sample
are phosphorylated (2.27%), Glu to Pyro-Glu (1.86%), Gln-Pyro-
Glu (0.6%) and dethiomethyl modified (0.41%) while peptides
predominantly expressed in GILT-WT lack these modifications.
However, higher percentage of peptides more abundantly
expressed in GILT-WT, show N-terminus acetylation (7.1% vs.
1.24%) and Pro to Pyro-Glu (10.7% vs. 0%).
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PLoS ONE | www.plosone.org 2 May 2010 | Volume 5 | Issue 5 | e10599Figure 1. Purification of MHC class II-associated peptides. A. RP-HPLC chromatogram of elution of the MHCII associated peptides.
System: Agilent 1100, Column: Agilent ZORBAX 300SB-C18, Flow rate : 1 mL/min and a gradient was created by mixing Solvent A: 0.1% TFA (v/v) in
CH3COOH(8.7%) and HCOOH(2.2%), pH1.9, and Solvent B: 0.08% TFA (v/v) in Acetonitrile; B. Dot blot of RP-HPLC fractions. 5 mL from each
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Mass spectrometry analysis of GILT2/2 and GILT-WT
samples was accomplished twice with similar results. However,
to confirm that at least some of identified peptides can bind to IA
b
molecules in vitro, we selected six peptides from the peptides
expressed either exclusively or at least ten fold more abundantly in
the GILT2/2 samples (Table 1 a, b) than in GILT-WT to test
their binding to MHC molecules in an in vitro assay. We used web-
based Rankpep software [9] to predict the affinities of 9 amino
acid IA
b-binding core of each peptide (Table 3). RANKPEP uses
Position Specific Scoring Matrices (PSSMs) or profiles from set
aligned peptides known to bind to a given MHC molecule as the
predictor of MHC-peptide binding and reports scores (sum of the
profile scores that match the residue type and position in the
profile) and percentile scores relative to the optimal sequence.
To further solidify the evidence, we used T2.IA
b cell line as
antigen presenting cell in peptide competition binding assay
between a known strong antigen and the peptides we found in our
study. Binding of peptides to IA
b was determined by flow
cytometry. T2.IA
b cells were incubated with Ea peptide 56–73
(ASFEAQGALANIAVDKA) known to bind to IA
b with a high
affinity [10]. Ea peptide bound to IA
b is specifically recognized by
Y-Ae antibody [11]. Peptides used for competition with Ea for
binding to IA
b are shown in Table 3. T2.IA
b cells were incubated
with either synthetic Ea 56–73 alone or Ea 56–73 in combination
with each one of the peptides from Table 3 for 1hr at 37uC.
Incubation of peptides at 4uC yielded identical results (data not
shown), however incubation at 37uC is mimics more closely
physiological conditions. Cells were then washed and incubated
with Y-Ae antibody and secondary antibody conjugated with PE.
Figure 2 shows that of six chosen peptides five peptides fully
diminish the binding of Y-Ae antibody and the sixth one had a
partial effect. This result suggests that chosen peptides were able to
out compete the binding of Ea 56–73 to IA
b and therefore
validates the results of our mass spec analysis. As a control for
specificity of binding to IA
b we used two peptides that bind to
H2K
b: RTYTYEKL and VGYMYETL [12]. As expected, neither
of these peptides was able to out compete Ea binding.
Discussion
Absence of lysosomal thiol reductase GILT can affect immune
responses to viral [13], [14], tumor [15], [16], and parasite
antigens (Dr. N. Nanda and Dr. M. Maric, unpublished), and can
affect the development of autoimmune diseases, such as experi-
mental allergic encephalomyelitis (Dr. N. Ruddle, unpublished
data) and diabetes [17]. The major mechanism is thought to be
deficient antigen processing and presentation in the absence of
GILT, as suggested by experiments using model antigens, where
GILT was required to reduce disulfide bonds of endocytosed
proteins leading to protein unfolding [4]. Reduced forms of
proteins are more amenable to further processing by lysosomal
proteases into peptides that eventually bind to MHC class II
molecules.
Present findings thus appear at odds with an expectation that
lack of GILT might lead to fewer antigens being presented by
MHC class II molecules. It should be pointed out, however, that
our current analysis evaluates steady state of processing and
presentation of permanently present self-antigens, whereas previ-
ous studies have assessed the ability of antigen processing
machinery to generate epitopes from antigens introduced in the
system at will (exogenously and transiently). It is therefore possible
fraction was applied to a blotting membrane and I-A
b molecules were detected as described in the text. C. Quantitative Imaging Analysis of
MHCII positive fractions from GILT-WT and GILT2/2 samples. MHC class II positive fractions from RP-HPLC were pooled for each sample and
three different amounts (high: 25 mL, medium: 12.5 mL, and low: 6mL) from each pool were loaded onto SDS-PAGE gel for quantitative imaging. D.
Flow cytometry analysis of GILT2/2 and GILT-WT splenocytes. Spleens were isolated, ground and red blood cells lysed in hypertonic buffer.
Washed and filtered splenocytes were incubated 30 min. on ice with anti-IA
b M5/114–PE antibody.
doi:10.1371/journal.pone.0010599.g001
Table 1. Peptides uniquely expressed by MHC class II isolated from GILT2/2 cells.
Peptide sequence Length (aa) Peptide Source Position* No of Cys**
ASSPAVTAP 9 Q9QY61 Iroquois homeodomain protein IRX-4 (515aa) 408–416 10
KLDLGSGGRALGGVGTAPAGGPAS iTRAQ4plex(K)@1 24 BAF64834.1 Apoptosis-associated Tyr kinase 3 (1424aa) 1080–1103 18
SPRIQLSSCRSLESLR Protein Terminal iTRAQ4plex@N-term,
Methylthio(C)@9
16 Q8BKW6 Putative uncharectarized protein
(Fragment) [Syde 2] (1096aa)
1–16 27
VGAVAAAEAAGLPGGGEGPKLAEG iTRAQ4plex(K)20 24 AAI50821.1 Magi1 protein (1280aa) 44–67 17
VGNVENTLFINTSNHGVF Oxidation(N)@3 18 O70472 Transmembrane protein 131 (Protein RW1)
[Tmem131] (1829aa)
130–147 12
GGAGGGGAGGGAGGGRSPVRELDM Deamidated(R)@20,
Oxidation(M)@24
24 P70390 Short stature homeobox protein 2
(Homeobox protein Og12X) (OG-12) (Paired family
homeodomain protein Prx3) [Shox2] (331aa)
91–99 4
LTMMSLTQPVLMGT Deamidated(Q)@8 15 B2RR86 2610002D18Rik protein
[2610002D18Rik] (339aa)
138–152 9
GGGGGGFGGSGG 12 NP031868.2 DEAH (Asp-Glu-Ala-His) box
polypeptide 9 (1383aa)
1253–1264 23
SGQEADSE 8 Q8C0D9 Centrosomal protein of 68 kDa
(Cep68) [Cep68] (733aa)
15–92 12
TLGTGKGT iTRAQ4PLEX(K)@6 8 P24860 G2/mitotic-specific cyclin-B1 [Ccnb1] (430aa) 68–75 5
*Position of peptide within protein.
**Number of cysteines in protein that was identified as a source of peptide.
doi:10.1371/journal.pone.0010599.t001
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presence or absence of GILT would have been reduced, or
perhaps annulated, if foreign proteins were expressed permanently
in the experimental system.
The above reasoning could explain findings of relatively equal
self-peptide representation in the absence or presence of GILT.
However, present data suggest overall more abundant peptide
presentation in the absence of GILT. It is possible that GILT may
influence activity of other enzymes or events involved in self-
protein processing. We have shown previously that oxidative stress
is increased in GILT2/2 cells [18]. Oxidative stress is known to
increase autophagy [19], [20] and therefore, we can speculate that
increased autophagy in GILT2/2 cells lead to increased variety
and quantity of proteins exposed to lysosomal enzymatic
Table 3. Peptides used for validation of peptide binding to IA
b.
Peptide sequence N-term MBS C-term Length Peptide source
Rankprep
score %OPT
1. *ASFEAQGALANIAVDKA SFE AGQGALANIA VDK 17aa Ea 56–73** 10.439 29.30%
2. *CASPLITTATFAYWGQGT CASPLITTA TFA 18aa AAX90134.1| immunoglobulin
heavy chain (24aa) FRAGMENT
13.912 39.04%
3. *SAQVVVGPVSEAEPPKASSA VGP VSEAAEPPKA SSA 20aa Q9D424 Calcium-binding tyrosine
phosphorylation-regulated protein
(Calcium-binding protein 86) (453aa)
11.814 33.16%
4. *SGAQPGGVPSAPTGPLGPP GGV PSAPTGPLG PP 19aa Q9Z1R2 Large proline-rich
protein BAT3 (1154 aa)
7.485 21.01%
5. ASSPAVTAP ASSPAVTAP 9aa Q9QY61 Iroquois homeodomain
protein IRX-4 (515aa)
7.092 19.90%
6. ATAGSGGVNGG A TAGSGGVNG G 11aa Q00PI9 Heterogeneous nuclear
ribonucleoprotein U-like protein 2
(MLF1-associated nuclear protein)
[Hnrnpul2] (745aa)
0.756 2.12%
7. AATEGTTAT AATEGTTAT 9aa Q6PGB8 Probable global
transcription activator SNF2L1
(Nucleosome-remodeling factor
subunit SNF2L) (ATP-dependent
helicase SMARCA1) (1046aa)
21.538 24.32%
8. ***RTYTYEKL 8aa N/A N/A
9. ***VGYMYETL 8aa N/A N/A
*Actual synthetic peptides used to validate binding to IA
b are in black.
**Ea 56–73 [39].
***Negative control peptides that bind to H2-K
b [12].
Matrix:I_A
b.p.mtx, Consensus: YYAPWCNNA, Optimal score 35.632, Binding threshold: 9.52.
Rank: Relative rank of predicted peptide (position specific scoring matrices (PSSM)).
%OPT -% score of the predicted peptide relative to that of consensus. The consensus is the sequence that yields max score.
MBS-Minimal Binding Sequence.
doi:10.1371/journal.pone.0010599.t003
Table 2. List of Peptide modifications.
Type of Modification 117:114,1 117:114.1 117:114,0.5 117:114.2
Total no. of peptides 511 28 483 5 341
Methylthio (C) 3 (10.7%) 45(9.3%) 0 31
Methylthio @N-term 0 3(0.62%) 0 2
Phosphorylation (S or T) 0 11(2.27%) 0 9
Protein terminal acetyl @N-term 2(7.1%) 6(1.24%) 1 1
Pro-.Pyro-Glu 3(10.7%) 0 0 0
Glu-. Pyro-Glu 0 9(1.86%) 0 7
Gln-.Pyro-Glu 0 3(0.6%) 0 3
Dethiomethyl 0 2(0.41%) 0 1
Dehydrated (all aa) 1(3.57%) 6(1.24%) 0 5
Total peptides modified 8(28.6%) 93(19.2%) 1 63
Total number of peptides labeled with both iTRAQ117 and iTRAQ114 labels is 511. 28 of these peptides were more abundantly expressed in MHCII from GILT-WT sample
(labeled with iTRAQ114) ,1, and 483 peptides were more abundant in GILT2/2 samples. The amount of MHC class II from GILT-WT and GILT2/2 sample was
normalized based on quantitative W. blot of IA
b.
doi:10.1371/journal.pone.0010599.t002
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b. T2.IA
b cells were incubated for 1h at 37uC with either Ea peptide 56–73 (ASFEAQGALANIAVDKA) alone, or
with mix of Ea peptide and individual peptides 2 to 6 listed in Table 3. Peptide Ea was used at 100 mM while competitor peptides 2–6 were used at
concentration of 2.5 mM. Upon incubation with peptide mix, cells were extensively washed in PBS and the binding of Ea 56–73 was detected by
Self-Peptides and GILT
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peptide species maybe expressed by MHC class II molecules at the
cell surface. This however remains to be tested in the future.
MHC class II-associated self-peptides are derived from proteins
that normally do not intersect the endocytic compartment and are
usually presented by the MHC class I pathway. However, previous
studies have shown that there is an extensive antigenic ‘‘cross-talk’’
between the classical MHC class I and class II presentation
pathways in professional APCs. For example, macrophages and
DCs efficiently perform MHC class I-mediated presentation of
exogenous protein antigens internalized by macropinocytosis or
phagocytosis [21], [22], [23]. Furthermore, Dongre, et al.
demonstrated examples of MHC class II-mediated presentation
of self–peptides [24]. These self-peptides could potentially gain
access to endosomal/lysosomal compartments through apoptosis,
necrosis, and/or autophagy. Therefore, in at least some cases self-
proteins may become exposed to the GILT-positive compartment
and their processing might be affected by GILT.
ESI-MS/MS was originally applied to the analysis of MHC
class I and MHC class II-associated peptides by Hunt, et al., where
650–2,000 different peptides bound to murine class II allele, I-A
d
were discovered [25]. However, peptide identification was limited
due to slow tandem mass spectral data acquisition, as well as
manual interpretation of peptide sequences. More recently
Dongre, et al., applied rapid, high throughput MHC-bound
peptide sequence analysis. Improved sample preparation was
combined with automated tandem mass-spectral data acquisition
and computer-assisted interpretation of tandem mass spectra [24].
The SEQUEST computer algorithm was used to compare
experimental and theoretically generated mass spectra. Using this
strategy, they characterized 128 mouse MHC class II (I-A
b)
associated peptides presented on the surface of B cells and
macrophages. We further improved the method for isolation of
MHC class II-associated peptides. Dongre, et al., used 2.5 M acetic
acid to separate peptides from MHC class II by ultracentrifugation
through a 10-kDa cut-off Amicon filter, prior to RP-HPLC
fractionation. This approach could potentially lead to a loss of a
portion of the sample due to the property of Amicon ultracentri-
fugation membrane. Instead, we directly applied the MHC class
II-bound peptide mixture to the RP-HPLC column at the acidic
condition (0.1% TFA, 8.7% acetic acid (1.5M) and 2.2% formic
acid (0.58M) in water) to achieve acid dissociation of the peptides
from MHC class II during the purification. The following gradient
step with acetonitrile separated short peptides from MHC class II
and other contaminants. In order to efficiently analyze samples
containing a large number peptides we used multi-dimensional
liquid chromatography together with automated tandem mass
spectral data acquisition on a QSTAR ELITE Hybrid LC/MS/
MS, with the latest AnalystH QS 2.0 software.
A large MS/MS dataset is valuable only if it can be efficiently
processed to identify peptide sequences. Comprehensive analysis
of peptides by the ProteinPILOT software with the Paragon
database search algorithm increased the number of peptides
found, improved sequence coverage, and increased peptide
identification (www.appliedbiosystems.com). Increasing the search
space by considering many more biological modifications and
imperfect enzymatic cleavages such as: Carboxamidomethyl Cys,
Deamidation, Oxidation (M), PyroGlutamic Acid (Q), O-Phos-
phoryl S/T/Y, Protein-N-Terminal Acetyl, allowed the identifi-
cation of significantly increased number of peptides in our study in
comparison to the similar studies performed in the past. Together,
these modifications in the peptide purification method and data
acquisition, allowed improvements in the quality and quantity of
the identified peptide sequences. Comparison of modifications in
peptides predominantly expressed in GILT-WT sample vs.
GILT2/2 sample did not show statistically significant differences
due to relatively small numbers of modified peptides (8 modified
peptides out of 28 predominantly expressed in GILT-WT, and 93
modified out of 483 predominantly expressed in GILT2/2
sample). However, several modifications were detected exclusively
in peptides from GILT2/2 sample: phosphorylation, methylthio
N-term, Glu and Gln to pyro-Glu and dethiomethyl. This raises a
possibility that GILT influences directly or indirectly posttransla-
tional modifications of certain proteins, but this remains to be
explored further in another study.
It is estimated that between 50 and 90% of proteins in human
body are modified posttranslationally. Protein and peptide
modifications have been shown to influence the immunogenicity
of peptides and proteins presented by MHC molecules [26], [27],
[28], either by creating neo antigens or masking antigens normally
recognized by the immune system. Therefore, peptide modifica-
tion plays important role in the autoimmune response as well as in
anti-tumor response and/or can be used as a strategy by
pathogens for their survival in the host. Several studies have
shown that posttranslational modification of self-peptides can
induce autoimmune response. For example the acetylated N-
terminal peptide of myelin basic protein is found to be required for
development of experimental autoimmune encephalomyelitis
(EAE) - a murine model of human multiple sclerosis. Nonacety-
lated peptide fails to stimulate T cells and will not elicit EAE [29].
Other examples are the findings that T cell responses specific for
phosphorylated aB–crystalline exist in EAE [30], while phosphor-
ylation of multiple antigens in Systemic Lupus Erythematosus
(SLE) induces diverse B cell response [31], [32], and deamidation
of wheat gliadin induces specific T and B cell responses in celiac
disease in humans [33], [34]. It has been shown also that for MHC
class I associated peptides deamidation, cysteinilation and
phosphorylation shape anti-tumor CTL response [35], [36],
[37]. In addition, reduction of cysteine containing epitopes of
nucleoprotein of influenza increases their immunogenicity 10–100
fold [28]. Therefore, it is possible that presence of different peptide
modifications in the absence of GILT may also contribute to
altered immune responses that were previously studied [4], [17].
In summary, labeling the GILT-WT sample with the iTRAQ
isotope tag-114, and the GILT2/2sample with the iTRAQ
isotope tag-117 allowed comparison of each identified peptide.
Quantitative data analysis based on the GILT KO/WT (114:117)
peptide ratio suggested overall increase of peptide amounts in the
GILT2/2 sample in comparison to the GILT-WT sample. In
addition, we identified a small subset of ten peptides exclusively
presented by MHC class II in the absence of GILT and another
subset of 18 peptides that are present in the GILT2/2 MHCII
pool 10 to 60 fold more abundantly than in the GILT-WT
MHCII pool. These findings suggest that the diversity of the MHC
class II-bound self-peptides presentation is only moderately
affected by the absence of GILT and that few neoepitopes emerge
incubation with YAe (anti-IA
b) antibody and secondary antibody conjugated with PE. Cells incubated only with YAe antibody and secondary antibody
without any peptide were used as a negative control. Presence of any of the competitor peptides 2–6, decreased the binding of Ea 56–73 signifying
the binding of peptides to IA
b and outcompeting the binding of Ea 56–73. Two peptides RTYTYEKL and VGYMYETL known to bind to H2-Kb [12]
served as negative control for specificity of binding.
doi:10.1371/journal.pone.0010599.g002
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that the absence of GILT alters the presentation of self-antigens on
the cell surface.
Materials and Methods
Mice, cells and antibodies
Spleens of one hundred C57BL/6.GILT-WT and one hundred
C57BL/6.GILT2/2 mice (8–12 weeks old) were used as a source
of the cells. Spleens were ground in PBS, pH 7.4 and red blood
cells were removed by lysis in ACK lysis buffer (150 mM NH4Cl.
10 mM KHCO3. 0.1 mM Na2EDTA). Splenocytes (5610
9) were
lysed in PBS, 1% NP-40, 20mM PMSF, 10mM TLCK, and
25 mM iodoacetamide, pH 7.4. T2.IA
b human cells were
obtained courtesy of Dr. P. Cresswell, Yale University. Antibodies.
Mouse IgG was purchased from Jackson laboratories, mouse anti-
Ia/peptide monoclonal antibody Y3jP [11] (specific for residues on
a-chain of IA
b that does not interact with free IA
b [38]) and rabbit
anti-MHC class II cytoplasmic tail (anti-CII) antibody with
specificity for a-chain as well, were a kind gift from Dr.
A.Rudensky (Memorial Sloan Kettering Cancer Center, NY).
Isolation of I-A
b
I-A
b was isolated by affinity chromatography on an mAb Y3jP-
sepharose column as previously described [39], [40]. Briefly,
purified antibodies (IgG and/or Y3jP) in a coupling buffer (0.2 M
NaHCO3, 0.5 M NaCl, pH 8.56) were mixed with prewashed
CNBr-activated sepharose 4B (GE Healthcare) overnight at 4uC.
Excess antibody was washed away with at least 5 volumes of the
coupling buffer. The sepharose slurry was resuspended in 0.1 M
Tris-HCl, pH 8.0, and incubated for 2 h at RT to block any
remaining active groups. The sepharose was washed alternately
with acidic and basic buffers for three cycles. Each cycle consisted
of a wash with 0.1 M acetate buffer, pH 4.0, containing 0.5M
NaCl followed by wash with the coupling buffer at pH 8.56.
A chain of affinity columns (uncoupled Protein A sepharose,
mouse IgG-Protein A sepharose, Y3jP-Protein A sepharose) were
washed with PBS and equilibrated in NP-40 lysis buffer. Filtered
lysate was sequentially run through these columns. Columns were
washed with at least 5 column volumes of lysis buffer with 1%
octyl-b-D-Glucopyranoside, until OD280 of the wash was equal or
less than 0.05U. 750 ml fractions were eluted with the Diethyl-
amine (DEA) buffer [25 mM Diethylamine (Sigma-Aldrich), 1%
octyl-b-D-Glucopyranoside (A.G. Scientific, INC), 150 mM NaCl,
25 mM PMSF, 10 mM TLCK, pH 10.5] and neutralized with
150 ml of the 0.5 M Tris pH 6.8. Western blot analysis using
rabbit anti-MHC class II cytoplasmic tail (anti-CII) antibody was
performed to test each fraction for the presence of MHC class II
protein. MHC class II containing fractions were combined for
each GILT-WT and/or GILT2/2 specimen respectively,
dialyzed against mQH2O( 3 61L), using Spectra/Por3 Dialysis
Membrane (Spectrum) with a molecular weight cut-off of
3,500 kDa, and lyophilized overnight.
Peptide elution
Reverse Phase High Performance Liquid Chromatography (RP-
HPLC) purification of I-A
b containing GILT-WT and GILT2/2
samples was performed on Agilent 1100 Chromatographic system
(Agilent Technologies). Chromatographic separation of peptides
and I-A
b molecules was achieved on Agilent Zorbax 300SB-C18
column (4.6 mm ID6150 mm, 5 mm), with an Agilent Zorbax
High Pressure, Reliance Cartridge, (4.6 mm ID612.5 mm)
Guard-Column. The aqueous solvent consisted of: 0.1% TFA,
8.7% acetic acid and 2.2% formic acid in HPLC quality water,
and the organic solvent consisted of 0.08% TFA in acetonitrile.
Flow rate was 1000 ml/min and the gradient was run from 0%
organic solvent to 100% organic solvent in 30min. 3561ml
fractions were collected for each GILT-WT and GILT2/2
sample.
Detection of I-A
b+ fractions and standardization of GILT-
WT and GILT2/2 samples
I-A
b positive fractions were detected by dot blot using rabbit
anti-CII (a chain specific) cytoplasmic tail antibody (1:500 dilution)
and goat-anti-rabbit HRP (1:2500 dilution). Immunoreactive
bands were visualized using the enhanced chemiluminescence
Western Lightning
tm (PerkinElmer) system. I-A
b positive fractions
(as detected by dot blot) were pooled for the quantification of
MHC class II molecules and the rest of the fractions were pooled
for mass spectrometry analysis of the MHC class II associated
peptides for the GILT-WT sample and the GILT2/2 sample,
separately. For the quantifications, aliquots of 25 ml, 12.5 ml and
6 ml from the GILT WT and the GILT2/2 pooled fractions
were separated by SDS-PAGE. Proteins were then transferred
onto PVFD membrane and I-A
b molecules detected by rabbit
anti-CII cytoplasmic tail Ab (1:500 dilution). IRDye
tm 800 goat
anti-rabbit secondary antibody (LI-COR Biosciences) was used as
the reporter. Bands were scanned using an Odyssey infrared
imaging system (LI-COR Biosciences), and analyzed/quantified
by the Odyssey 2.1 software (LI-COR Biosciences).
iTRAQ labeling of peptides (GILT-WT and GILT2/2 I-A
b
negative fractions)
iTRAQ (isobaric tags for relative quantitation) labeling was
performed according to the manufacturer’s instructions (Applied
Biosciences). Two isotopes (114 and 117) from the fourplex (114,
115, 116, and 117 m/z reporter ions) iTRAQH reagent were used.
Due to the isobaric mass design of the iTRAQ reagents,
differentially labeled proteins do not differ in mass. Relative
quantification of proteins is achieved by comparing peak
intensities of reporter ions observed in fragmentation spectra of
iTRAQ-labeled peptides. The GILT-WT samples were labeled
with the iTRAQ-114, and the GILT2/2 samples were labeled
with the iTRAQ-117, under identical conditions. These two
differently labeled samples (GILT-WT iTRAQ114, and GILT2/2
iTRAQ117) were combined right after labeling to ensure identical
conditions for the rest of the procedure.
Ion Exchange Chromatography
5 mM sodium phosphate buffer, pH 3.0, 15% acetonitrile was
added to the iTRAQ labeled sample and sample was filtered
through a 0.2 mm syringe filter. The samples were applied to the
SP-PEEK (SulfoPropyl-Polyetheretherketone) ion exchange col-
umn (Waters Corporation) equilibrated with sodium phosphate
buffer. Buffer A (5mM sodium phosphate buffer, pH 3.0, 15%
acetonitrile) and buffer B (same as buffer A with the addition of
1M NaCl) were used to create a gradient starting from 0 to 40% B
(20ml), and to 100% B (5ml). Total of 17 fractions were collected
and desalted with MacroSpin
TM Columns (The Nest Group, Inc.,
Southboro, MA).
Nano-Liquid Chromatography-Electrospray ionization
Tandem Mass Spectrometry (Nano-LC-ESI-MS/MS)
Nanoflow chromatography was performed with a Tempo
TM
nano system (Applied Biosystems). A 5ml sample was injected onto
the 75 mm, C18 reverse phase column (Vydac C18), at a flow rate
of 200 ml/min, and operating pressure of 1,200 psi. The peptides
Self-Peptides and GILT
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120 min period with a flow rate of 300 nl/min, and a total run
time of 150 min. Samples from the reverse-phase column were
inserted directly into the nano electrospray needle using a QSTAR
ELITE Hybrid LC/MS/MS (Applied Biosystems), a high
performance quadrupole time-of-flight (QqTOF) mass spectrom-
eter with AnalystH QS 2.0 software. ProteinPilot
TM 2.0 software
with the Paragon
TM Algorithm (Applied Biosystems) was used for
post data analysis. The novel Paragon
TM Algorithm for database
searching can efficiently consider about 150 modifications and
unexpected cleavages to identify peptides from MS/MS spectra.
Supporting Information
Table S1 A large amount of data collected from the mass
spectrometer was rapidly processed by analysis software Protein
PILOT with the search engine PARAGON [5] to identify peptides
sequences of I-Ab-bound peptides which resulted in the detection
of more than 5,000 peptide species. Of these, 511 distinct peptides
with iTRAQ117 (GILT2/2 sample) and/or iTRAQ114 (WT
sample) were considered statistically significant based on the
confidence score associated with the peptide identification. These
peptides are listed in Supplementary Table 1.
Found at: doi:10.1371/journal.pone.0010599.s001 (0.11 MB
XLS)
Table S2
Found at: doi:10.1371/journal.pone.0010599.s002 (0.07 MB
DOC)
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